A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy
Clinical trial NCT00407212 · COMPLETED
Trial details
- NCT number
- NCT00407212
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2003-11-01
- Enrollment
- 301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.